Drawing for VIRACOR

USPTO serial 98532674

VIRACOR

Reviewed by CopyMark Law Group

Reg. 7972330Status 700Registered
Filing date
Status date
Registration date
Oct 7, 2025
Examiner
QUILICI, BRENDAN A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VIRACOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph Sofer

110 West 40th StreetSuite 2001New York, NY 10128

Goods and services

ClassDescriptionStatusFirst use
042Scientific research and industrial research in the field of infectious disease, pre- and post-transplant, allergy, invasive fungal and immunology testing; Research and development in the fields of microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; Carrying out scientific study and research in the field of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological or immunological analyses, clinical and in-vitro studies in the chemical, pharmaceutical, cosmetic, personal care, biotechnology, and any science-oriented industries; Carrying out scientific study and research in the field of genetic analyses in the fields of human and animal products; Carrying out scientific study and research in the field of genetic analyses in the chemical, pharmaceutical and biotechnology industries; Scientific and development services, namely, development of methods namely, establishment and carrying out of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, immunological and biomolecular testing methods; Scientific and medical research services, namely preparing scientific and medical expert reports for scientists; Technical project studies, namely conducting scientific feasibility studies; Professional consultancy in the field of scientific and medical research; DNA, RNA and virus analyses for scientific research purposes; Scientific and technological services namely, scientific research, scientific analysis, environmental inspection, scientific research consulting, industrial design, engineering, scientific development and genetic laboratory testing services for scientific research purposes for others; Providing reagent sample testing services featuring the collection of material for genetic testing for scientific research purposes; On-line data collection and provision services, namely, providing an online searchable database in the field of pharmaceutical testing; consultancy and advisory services related to pharmaceutical testing; Scientific and technological services related to the development, commercialization, life cycle management, and improvement of products, namely scientific research, analysis, and testing in the field of consumer products manufactured by pharmaceutical, chemical, biotechnology, and other science-oriented industries; Scientific research, analysis and testing in the field of regulatory compliance of products manufactured by pharmaceutical, chemical, biotechnology, and other science-oriented industries; Scientific research consulting and advisory services in the field of infectious disease, transplantation, allergy, invasive fungal and immunology related to analytical techniques and product development processes; Product development consulting and advisory services related to the development, life cycle management, and improvement of products manufactured by pharmaceutical, chemical, biotechnology, and other science-oriented industries; Product development and product development advisory services for others; Database design and development; Providing online information about industrial analysis and research services in the field of infectious disease, pre- and post-transplant, allergy, invasive fungal and immunology testing; Providing an online searchable database with algorithms in the field of scientific analysis results based on genomics data for scientific research purposes; Providing online information in the field of technological research in the field of infectious disease, pre- and post-transplant, allergy, invasive fungal and immunology testing from a computer database or the Internet; Product safety testing; Testing of new products for others; Quality control testing of products, namely product quality testing to determine conformity with certification standards; Scientific and technical research for others in the field of pharmaceuticals, biotech products and chemicals; Pharmaceutical drug discovery services; Development and research in the fields of pharmaceuticals, biotech products, chemicals; Scientific research in the nature of conducting clinical trials for pharmaceutical drugs for others; Scientific research services in the areas of virology, genomics, proteomics, chemistry, pharmacology, biology, epidemiology, medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry and computational chemistry; Providing scientific information in the field of epidemiology, genomics and proteomics of living organisms including human beings based on existing biological data by using information technology tools and techniques; Scientific research in the nature of conducting clinical trials for pharmaceutical products for others; Testing of pharmaceuticals for ensuring safety and efficiency of pharmaceutical drugs; Scientific research featuring the use of information technology tools and techniques to work with existing biological data and to generate information on the epidemiology, genomics and proteomics of living organisms including human beings through research and study; Scientific and technological services, namely scientific and medical research laboratory services, medical laboratory research and product research and development in the fields of pharmaceutical drug development, epidemiology, biomedicine and biobanking; Qualify management services, namely consultation and analysis services in the fields of biotechnology, pharmaceutical research and product development, pharmaceutical diagnostics research and drug therapy; Clinical research in the field of pharmaceutical and biopharmaceutical industries for others; Product development for others in the field of pharmaceutical and biopharmaceutical productsACTIVEApr 1, 2000
044Medical testing services namely blood testing, saliva, urine, tissue, hair and body fluid testing services; Medical and veterinary testing services, namely, serological and urinary testing services for medical, epidemiological and veterinary purposes; Medical testing services in the field of epidemiology and genetics ; DNA and RNA screening for medical purposes; Viral screening for medical purposes; Medical and health services in connection with DNA and RNA, namely DNA and RNA screening for medical purposes; Genetic testing for medical purposes; Hospital services; Medical assistance services relating to transplant patients; Medical assistance services; Services in the field of epidemiology and genetics, namely genetic testing for medical purposes; Medical clinic services; Medical consultation services; Genetic and epidemiological consultation, in the nature of genetic counseling; Provision of medical record services online, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Human fertility treatment services; Collection, sampling and preservation of human blood, saliva, urine, tissue, hair and body fluids for medical diagnostic and treatment purposes; Medical testing for diagnostic and epidemiological purposes; Medical diagnostic monitoring and reporting services in the field of cardiovascular diseases; Providing information relating to cardiovascular health; Medical services namely wellness programs for improving health and quality of life in the field of cardiovascular diseases; Medical testing for diagnostic and treatment purposes namely for genetic causes of lipid abnormalities; Medical diagnostic testing in the field of diabetes; Medical testing for diagnostic purposes in the field of preventive medicine; Carrying out test panels in the nature of medical testing for diagnostic or treatment purposes in the field of preventive medicine; Medical services namely, preventive medical services and medical diagnostic testing in the field of micro-nutrition; Medical diagnostic testing in the field of sports injuries; Medical diagnostic testing in the field of anti-ageing medicine; Medical assistance services in the field of preventive medicine; Carrying out medical biology test panels, in the nature of medical testing for diagnostic or treatment purposes; Medical information services, namely, interpretation of medical biology test results; Providing medical information and advisory services in the field of bio-pathological information and advice relating to medical biology tests; Medical testing for diagnostic and treatment purposes for assessing immunogenicity, hypersensitivity and adverse immune stimulation; Medical testing services in the field of allergy and immunology testing; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Prenatal diagnostic testing for medical purposes; Prenatal medical diagnostic testing; Professional consultancy in the field of medical treatment of infectious disease, pre- and post-transplant, allergy and invasive fungal infections; Gene libraries in the nature of gene bank services for collection of DNA and RNA fragments, variants or combination of genes of chemical nature for medical useACTIVEApr 1, 2000

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 7, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 3, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 13, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2025XAECEXAMINER'S AMENDMENT ENTERED
Jul 10, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 10, 2025GNEAEXAMINERS AMENDMENT E-MAILED
Jul 10, 2025CNEAEXAMINERS AMENDMENT -WRITTEN
May 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 14, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 25, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 25, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2024DOCKASSIGNED TO EXAMINER
Oct 30, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2024NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance